Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir.

MLA

Waters, Michael D., et al. “Human Genetic Risk of Treatment with Antiviral Nucleoside Analog Drugs That Induce Lethal Mutagenesis: The Special Case of Molnupiravir.” Environmental and Molecular Mutagenesis, vol. 63, no. 1, Jan. 2022, pp. 37–63. EBSCOhost, https://doi.org/10.1002/em.22471.

APA

Waters, M. D., Warren, S., Hughes, C., Lewis, P., & Zhang, F. (2022). Human genetic risk of treatment with antiviral nucleoside analog drugs that induce lethal mutagenesis: The special case of molnupiravir. Environmental and Molecular Mutagenesis, 63(1), 37–63. https://doi.org/10.1002/em.22471

Chicago

Waters, Michael D, Stafford Warren, Claude Hughes, Philip Lewis, and Fengyu Zhang. 2022. “Human Genetic Risk of Treatment with Antiviral Nucleoside Analog Drugs That Induce Lethal Mutagenesis: The Special Case of Molnupiravir.” Environmental and Molecular Mutagenesis 63 (1): 37–63. doi:10.1002/em.22471.